{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:25:09Z","timestamp":1791303909948,"version":"4.1.0"},"reference-count":217,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T00:00:00Z","timestamp":1304380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00439-011-0995-8","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T05:47:51Z","timestamp":1304315271000},"page":"583-605","source":"Crossref","is-referenced-by-count":77,"title":["RNAi: a potential new class of therapeutic for human genetic disease"],"prefix":"10.1007","volume":"130","author":[{"given":"Attila A.","family":"Seyhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,3]]},"reference":[{"issue":"2\u20133","key":"995_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2007.03.005","volume":"59","author":"L Aagaard","year":"2007","unstructured":"Aagaard L, Rossi JJ (2007) RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 59(2\u20133):75\u201386","journal-title":"Adv Drug Deliv Rev"},{"issue":"20","key":"995_CR2","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1093\/hmg\/ddg280","volume":"12","author":"A Abdelgany","year":"2003","unstructured":"Abdelgany A, Wood M et al (2003) Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. Hum Mol Genet 12(20):2637\u20132644","journal-title":"Hum Mol Genet"},{"issue":"1","key":"995_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y et al (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25(1):239\u2013252","journal-title":"Neuron"},{"issue":"12","key":"995_CR4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/nbt1042","volume":"22","author":"S Agrawal","year":"2004","unstructured":"Agrawal S, Kandimalla ER (2004) Role of Toll-like receptors in antisense and siRNA [corrected]. Nat Biotechnol 22(12):1533\u20131537","journal-title":"Nat Biotechnol"},{"issue":"7","key":"995_CR5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2010.81","volume":"6","author":"I Alevizos","year":"2010","unstructured":"Alevizos I, Illei GG (2010a) MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 6(7):391\u2013398","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"995_CR6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.autrev.2010.05.009","volume":"9","author":"I Alevizos","year":"2010","unstructured":"Alevizos I, Illei GG (2010b) MicroRNAs in Sjogren\u2019s syndrome as a prototypic autoimmune disease. Autoimmun Rev 9(9):618\u2013621","journal-title":"Autoimmun Rev"},{"issue":"2","key":"995_CR7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/nar\/gkg147","volume":"31","author":"M Amarzguioui","year":"2003","unstructured":"Amarzguioui M, Holen T et al (2003) Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 31(2):589\u2013595","journal-title":"Nucleic Acids Res"},{"issue":"7006","key":"995_CR8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350\u2013355","journal-title":"Nature"},{"issue":"2","key":"995_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1517\/14712598.5.2.221","volume":"5","author":"M Ameyar-Zazoua","year":"2005","unstructured":"Ameyar-Zazoua M, Guasconi V et al (2005) siRNA as a route to new cancer therapies. Expert Opin Biol Ther 5(2):221\u2013224","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"995_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1358\/dnp.2010.23.6.1437713","volume":"23","author":"P Arbuthnot","year":"2010","unstructured":"Arbuthnot P (2010) Harnessing RNA interference for the treatment of viral infections. Drug News Perspect 23(6):341\u2013350","journal-title":"Drug News Perspect"},{"issue":"7","key":"995_CR11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/07853890410018817","volume":"36","author":"S Barik","year":"2004","unstructured":"Barik S (2004) Development of gene-specific double-stranded RNA drugs. Ann Med 36(7):540\u2013551","journal-title":"Ann Med"},{"issue":"2","key":"995_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297","journal-title":"Cell"},{"issue":"2","key":"995_CR13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215\u2013233","journal-title":"Cell"},{"issue":"1","key":"995_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","volume":"104","author":"DJ Begley","year":"2004","unstructured":"Begley DJ (2004) Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther 104(1):29\u201345","journal-title":"Pharmacol Ther"},{"issue":"4","key":"995_CR15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/oli.2008.0164","volume":"18","author":"MA Behlke","year":"2008","unstructured":"Behlke MA (2008) Chemical modification of siRNAs for in vivo use. Oligonucleotides 18(4):305\u2013319","journal-title":"Oligonucleotides"},{"issue":"7323","key":"995_CR16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/468519a","volume":"468","author":"A Berns","year":"2010","unstructured":"Berns A (2010) Cancer: the blind spot of p53. Nature 468(7323):519\u2013520","journal-title":"Nature"},{"issue":"4","key":"995_CR17","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1172\/JCI5346","volume":"103","author":"CI Berul","year":"1999","unstructured":"Berul CI, Maguire CT et al (1999) DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest 103(4):R1\u2013R7","journal-title":"J Clin Invest"},{"issue":"3","key":"995_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nmeth854","volume":"3","author":"A Birmingham","year":"2006","unstructured":"Birmingham A, Anderson EM et al (2006) 3\u2032 UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 3(3):199\u2013204","journal-title":"Nat Methods"},{"issue":"2","key":"995_CR19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/bc060349x","volume":"18","author":"RJ Boado","year":"2007","unstructured":"Boado RJ, Zhang Y et al (2007) Fusion antibody for Alzheimer\u2019s disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation. Bioconjug Chem 18(2):447\u2013455","journal-title":"Bioconjug Chem"},{"issue":"9","key":"995_CR20","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1528-1167.2010.02672.x","volume":"51","author":"D Boison","year":"2010","unstructured":"Boison D (2010) Inhibitory RNA in epilepsy: research tools and therapeutic perspectives. Epilepsia 51(9):1659\u20131668","journal-title":"Epilepsia"},{"issue":"6","key":"995_CR21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, McBride JL et al (2009) Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice. Mol Ther 17(6):1053\u20131063","journal-title":"Mol Ther"},{"issue":"3","key":"995_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1535-6108(02)00122-8","volume":"2","author":"TR Brummelkamp","year":"2002","unstructured":"Brummelkamp TR, Bernards R et al (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2(3):243\u2013247","journal-title":"Cancer Cell"},{"issue":"12","key":"995_CR23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","volume":"2","author":"D Bumcrot","year":"2006","unstructured":"Bumcrot D, Manoharan M et al (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2(12):711\u2013719","journal-title":"Nat Chem Biol"},{"issue":"6","key":"995_CR24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0092-8674(95)90273-2","volume":"82","author":"EN Burright","year":"1995","unstructured":"Burright EN, Clark HB et al (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82(6):937\u2013948","journal-title":"Cell"},{"issue":"5","key":"995_CR25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care A, Catalucci D et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13(5):613\u2013618","journal-title":"Nat Med"},{"issue":"7228","key":"995_CR26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature07758","volume":"457","author":"D Castanotto","year":"2009","unstructured":"Castanotto D, Rossi JJ (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457(7228):426\u2013433","journal-title":"Nature"},{"issue":"9","key":"995_CR27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","volume":"11","author":"CK Cemal","year":"2002","unstructured":"Cemal CK, Carroll CJ et al (2002) YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. Hum Mol Genet 11(9):1075\u20131094","journal-title":"Hum Mol Genet"},{"issue":"5","key":"995_CR28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","volume":"26","author":"TC Chang","year":"2007","unstructured":"Chang TC, Wentzel EA et al (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26(5):745\u2013752","journal-title":"Mol Cell"},{"issue":"11","key":"995_CR29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nrg2179","volume":"8","author":"EJ Chapman","year":"2007","unstructured":"Chapman EJ, Carrington JC (2007) Specialization and evolution of endogenous small RNA pathways. Nat Rev Genet 8(11):884\u2013896","journal-title":"Nat Rev Genet"},{"issue":"1","key":"995_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood.V69.1.109.109","volume":"69","author":"S Charache","year":"1987","unstructured":"Charache S, Dover GJ et al (1987) Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood 69(1):109\u2013116","journal-title":"Blood"},{"issue":"12","key":"995_CR31","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI200420673","volume":"113","author":"J Chen","year":"2004","unstructured":"Chen J, Wall NR et al (2004) Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin. J Clin Invest 113(12):1784\u20131791","journal-title":"J Clin Invest"},{"issue":"5","key":"995_CR32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuron.2007.05.017","volume":"54","author":"HY Cheng","year":"2007","unstructured":"Cheng HY, Papp JW et al (2007) microRNA modulation of circadian-clock period and entrainment. Neuron 54(5):813\u2013829","journal-title":"Neuron"},{"issue":"2","key":"995_CR33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbadis.2006.05.013","volume":"1772","author":"DH Cho","year":"2007","unstructured":"Cho DH, Tapscott SJ (2007) Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 1772(2):195\u2013204","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"995_CR34","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1093\/nar\/gkl388","volume":"34","author":"TC Chu","year":"2006","unstructured":"Chu TC, Twu KY et al (2006) Aptamer mediated siRNA delivery. Nucleic Acids Res 34(10):e73","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"995_CR35","first-page":"189","volume":"11","author":"JH Chua","year":"2009","unstructured":"Chua JH, Armugam A et al (2009) MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 11(2):189\u2013199","journal-title":"Curr Opin Mol Ther"},{"issue":"2","key":"995_CR36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1212\/WNL.59.2.162","volume":"59","author":"R Croxen","year":"2002","unstructured":"Croxen R, Hatton C et al (2002) Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology 59(2):162\u2013168","journal-title":"Neurology"},{"issue":"6","key":"995_CR37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.gt.3302656","volume":"13","author":"BR Cullen","year":"2006","unstructured":"Cullen BR (2006) Induction of stable RNA interference in mammalian cells. Gene Ther 13(6):503\u2013508","journal-title":"Gene Ther"},{"issue":"4","key":"995_CR38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1044-579X(03)00042-7","volume":"13","author":"C Damm-Welk","year":"2003","unstructured":"Damm-Welk C, Fuchs U et al (2003) Targeting oncogenic fusion genes in leukemias and lymphomas by RNA interference. Semin Cancer Biol 13(4):283\u2013292","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"995_CR39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.neuron.2007.02.020","volume":"53","author":"BL Davidson","year":"2007","unstructured":"Davidson BL, Boudreau RL (2007) RNA interference: a tool for querying nervous system function and an emerging therapy. Neuron 53(6):781\u2013788","journal-title":"Neuron"},{"issue":"5","key":"995_CR40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrn1104","volume":"4","author":"BL Davidson","year":"2003","unstructured":"Davidson BL, Breakefield XO (2003) Viral vectors for gene delivery to the nervous system. Nat Rev Neurosci 4(5):353\u2013364","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"995_CR41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(04)00678-7","volume":"3","author":"BL Davidson","year":"2004","unstructured":"Davidson BL, Paulson HL (2004) Molecular medicine for the brain: silencing of disease genes with RNA interference. Lancet Neurol 3(3):145\u2013149","journal-title":"Lancet Neurol"},{"issue":"7291","key":"995_CR42","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","volume":"464","author":"ME Davis","year":"2010","unstructured":"Davis ME, Zuckerman JE et al (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291):1067\u20131070","journal-title":"Nature"},{"issue":"6","key":"995_CR43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrd2310","volume":"6","author":"A Fougerolles de","year":"2007","unstructured":"de Fougerolles A, Vornlocher HP et al (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6(6):443\u2013453","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"995_CR44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.gt.3302664","volume":"13","author":"EM Denovan-Wright","year":"2006","unstructured":"Denovan-Wright EM, Davidson BL (2006) RNAi: a potential therapy for the dominantly inherited nucleotide repeat diseases. Gene Ther 13(6):525\u2013531","journal-title":"Gene Ther"},{"issue":"10 Suppl","key":"995_CR45","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.earlhumdev.2009.08.013","volume":"85","author":"JP DeVincenzo","year":"2009","unstructured":"DeVincenzo JP (2009) Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials. Early Hum Dev 85(10 Suppl):S31\u2013S35","journal-title":"Early Hum Dev"},{"issue":"43","key":"995_CR46","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia M, Sena-Esteves M et al (2007) Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci USA 104(43):17204\u201317209","journal-title":"Proc Natl Acad Sci USA"},{"key":"995_CR47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.physiol.67.040403.130716","volume":"67","author":"CP Dillon","year":"2005","unstructured":"Dillon CP, Sandy P et al (2005) Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processes. Annu Rev Physiol 67:147\u2013173","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"995_CR48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1474-9728.2003.00054.x","volume":"2","author":"H Ding","year":"2003","unstructured":"Ding H, Schwarz DS et al (2003) Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2(4):209\u2013217","journal-title":"Aging Cell"},{"issue":"4","key":"995_CR49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.1064703","volume":"17","author":"JG Doench","year":"2003","unstructured":"Doench JG, Petersen CP et al (2003) siRNAs can function as miRNAs. Genes Dev 17(4):438\u2013442","journal-title":"Genes Dev"},{"issue":"7","key":"995_CR50","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/mt.2008.98","volume":"16","author":"L Dore-Savard","year":"2008","unstructured":"Dore-Savard L, Roussy G et al (2008) Central delivery of Dicer-substrate siRNA: a direct application for pain research. Mol Ther 16(7):1331\u20131339","journal-title":"Mol Ther"},{"issue":"3","key":"995_CR51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","volume":"65","author":"V Drouet","year":"2009","unstructured":"Drouet V, Perrin V et al (2009) Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol 65(3):276\u2013285","journal-title":"Ann Neurol"},{"issue":"6","key":"995_CR52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrm1129","volume":"4","author":"DM Dykxhoorn","year":"2003","unstructured":"Dykxhoorn DM, Novina CD et al (2003) Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4(6):457\u2013467","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"15","key":"995_CR53","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1073\/pnas.0601309103","volume":"103","author":"DM Dykxhoorn","year":"2006","unstructured":"Dykxhoorn DM, Schlehuber LD et al (2006) Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism. Proc Natl Acad Sci USA 103(15):5953\u20135958","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"995_CR54","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1101\/gad.862301","volume":"15","author":"SM Elbashir","year":"2001","unstructured":"Elbashir SM, Lendeckel W et al (2001a) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15(2):188\u2013200","journal-title":"Genes Dev"},{"issue":"23","key":"995_CR55","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1093\/emboj\/20.23.6877","volume":"20","author":"SM Elbashir","year":"2001","unstructured":"Elbashir SM, Martinez J et al (2001b) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20(23):6877\u20136888","journal-title":"EMBO J"},{"issue":"3","key":"995_CR56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archneur.62.3.353","volume":"62","author":"JL Eriksen","year":"2005","unstructured":"Eriksen JL, Wszolek Z et al (2005) Molecular pathogenesis of Parkinson disease. Arch Neurol 62(3):353\u2013357","journal-title":"Arch Neurol"},{"issue":"4","key":"995_CR57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1399-0004.2008.01076.x","volume":"74","author":"AE Erson","year":"2008","unstructured":"Erson AE, Petty EM (2008) MicroRNAs in development and disease. Clin Genet 74(4):296\u2013306","journal-title":"Clin Genet"},{"issue":"7323","key":"995_CR58","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature09535","volume":"468","author":"DM Feldser","year":"2010","unstructured":"Feldser DM, Kostova KK et al (2010) Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature 468(7323):572\u2013575","journal-title":"Nature"},{"issue":"6\u20137","key":"995_CR59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0960-8966(01)00201-2","volume":"11","author":"KM Flanigan","year":"2001","unstructured":"Flanigan KM, Coffeen CM et al (2001) Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy. Neuromuscul Disord 11(6\u20137):525\u2013529","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"995_CR60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E et al (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27(1):59\u201365","journal-title":"Nat Biotechnol"},{"issue":"5","key":"995_CR61","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","volume":"16","author":"NR Franich","year":"2008","unstructured":"Franich NR, Fitzsimons HL et al (2008) AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington\u2019s disease. Mol Ther 16(5):947\u2013956","journal-title":"Mol Ther"},{"issue":"1","key":"995_CR62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bioeng.2006.01.002","volume":"23","author":"AL Gartel","year":"2006","unstructured":"Gartel AL, Kandel ES (2006) RNA interference in cancer. Biomol Eng 23(1):17\u201334","journal-title":"Biomol Eng"},{"key":"995_CR63","doi-asserted-by":"crossref","unstructured":"Gaur RK (2006) RNA interference: a potential therapeutic tool for silencing splice isoforms linked to human diseases. Biotechniques 40:S15\u2013S22. doi: 10.2144\/000112165","DOI":"10.2144\/000112165"},{"issue":"2","key":"995_CR64","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrg2504","volume":"10","author":"M Ghildiyal","year":"2009","unstructured":"Ghildiyal M, Zamore PD (2009) Small silencing RNAs: an expanding universe. Nat Rev Genet 10(2):94\u2013108","journal-title":"Nat Rev Genet"},{"issue":"52","key":"995_CR65","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.1038\/sj.onc.1207879","volume":"23","author":"CS Gondi","year":"2004","unstructured":"Gondi CS, Lakka SS et al (2004) RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene 23(52):8486\u20138496","journal-title":"Oncogene"},{"issue":"7","key":"995_CR66","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ncpneuro0551","volume":"3","author":"P Gonzalez-Alegre","year":"2007","unstructured":"Gonzalez-Alegre P, Paulson HL et al (2007) Technology insight: therapeutic RNA interference\u2013how far from the neurology clinic? Nat Clin Pract Neurol 3(7):394\u2013404","journal-title":"Nat Clin Pract Neurol"},{"issue":"3","key":"995_CR67","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mt.2009.292","volume":"18","author":"SJ Gray","year":"2010","unstructured":"Gray SJ, Blake BL et al (2010) Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB). Mol Ther 18(3):570\u2013578","journal-title":"Mol Ther"},{"issue":"7","key":"995_CR68","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/mt.2008.85","volume":"16","author":"MA Graziewicz","year":"2008","unstructured":"Graziewicz MA, Tarrant TK et al (2008) An endogenous TNF-alpha antagonist induced by splice-switching oligonucleotides reduces inflammation in hepatitis and arthritis mouse models. Mol Ther 16(7):1316\u20131322","journal-title":"Mol Ther"},{"issue":"7014","key":"995_CR69","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature03120","volume":"432","author":"RI Gregory","year":"2004","unstructured":"Gregory RI, Yan KP et al (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432(7014):235\u2013240","journal-title":"Nature"},{"key":"995_CR70","doi-asserted-by":"crossref","unstructured":"Grimm D, Kay MA (2007) RNAi and gene therapy: a mutual attraction. Hematol Am Soc Hematol Educ Program 473\u2013481","DOI":"10.1182\/asheducation-2007.1.473"},{"issue":"7092","key":"995_CR71","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm D, Streetz KL et al (2006) Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature 441(7092):537\u2013541","journal-title":"Nature"},{"key":"995_CR300","doi-asserted-by":"crossref","unstructured":"Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX et al (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264(5166):1772\u20131775","DOI":"10.1126\/science.8209258"},{"issue":"4","key":"995_CR72","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","volume":"363","author":"S Hacein-Bey-Abina","year":"2010","unstructured":"Hacein-Bey-Abina S, Hauer J et al (2010) Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 363(4):355\u2013364","journal-title":"N Engl J Med"},{"issue":"5441","key":"995_CR73","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.286.5441.950","volume":"286","author":"AJ Hamilton","year":"1999","unstructured":"Hamilton AJ, Baulcombe DC (1999) A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286(5441):950\u2013952","journal-title":"Science"},{"issue":"6775","key":"995_CR74","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/35005107","volume":"404","author":"SM Hammond","year":"2000","unstructured":"Hammond SM, Bernstein E et al (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404(6775):293\u2013296","journal-title":"Nature"},{"issue":"Pt 24","key":"995_CR75","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1242\/jcs.114.24.4557","volume":"114","author":"J Harborth","year":"2001","unstructured":"Harborth J, Elbashir SM et al (2001) Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114(Pt 24):4557\u20134565","journal-title":"J Cell Sci"},{"issue":"5","key":"995_CR76","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ymthe.2006.02.004","volume":"13","author":"TC Harding","year":"2006","unstructured":"Harding TC, Lalani AS et al (2006) AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma. Mol Ther 13(5):956\u2013966","journal-title":"Mol Ther"},{"issue":"5580","key":"995_CR77","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356","journal-title":"Science"},{"issue":"8674","key":"995_CR78","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)91867-9","volume":"2","author":"PS Harper","year":"1989","unstructured":"Harper PS (1989) Postoperative complications in myotonic dystrophy. Lancet 2(8674):1269","journal-title":"Lancet"},{"issue":"8","key":"995_CR79","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archneurol.2009.180","volume":"66","author":"SQ Harper","year":"2009","unstructured":"Harper SQ (2009) Progress and challenges in RNA interference therapy for Huntington disease. Arch Neurol 66(8):933\u2013938","journal-title":"Arch Neurol"},{"issue":"16","key":"995_CR80","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD et al (2005) RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci USA 102(16):5820\u20135825","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7043","key":"995_CR81","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, Thomson JM et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435(7043):828\u2013833","journal-title":"Nature"},{"issue":"8","key":"995_CR82","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/nar\/30.8.1757","volume":"30","author":"T Holen","year":"2002","unstructured":"Holen T, Amarzguioui M et al (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res 30(8):1757\u20131766","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"995_CR83","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm1191","volume":"11","author":"V Hornung","year":"2005","unstructured":"Hornung V, Guenthner-Biller M et al (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 11(3):263\u2013270","journal-title":"Nat Med"},{"issue":"1","key":"995_CR84","first-page":"11","volume":"21","author":"WA Horton","year":"2005","unstructured":"Horton WA (2005) Therapeutic RNAi for genetic skeletal disease? Growth Genet Horm 21(1):11\u201312","journal-title":"Growth Genet Horm"},{"issue":"4","key":"995_CR85","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/hum.2006.160","volume":"18","author":"B Huang","year":"2007","unstructured":"Huang B, Schiefer J et al (2007) High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo. Hum Gene Ther 18(4):303\u2013311","journal-title":"Hum Gene Ther"},{"issue":"19","key":"995_CR86","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1158\/0008-5472.CAN-05-0565","volume":"65","author":"S Hu-Lieskovan","year":"2005","unstructured":"Hu-Lieskovan S, Heidel JD et al (2005) Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing\u2019s sarcoma. Cancer Res 65(19):8984\u20138992","journal-title":"Cancer Res"},{"issue":"6822","key":"995_CR87","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"I. H. G. S. Consortium","year":"2001","unstructured":"I. H. G. S. Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409(6822):860\u2013921","journal-title":"Nature"},{"key":"995_CR88","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1196\/annals.1348.060","volume":"1082","author":"H Ilves","year":"2006","unstructured":"Ilves H, Kaspar RL et al (2006) Inhibition of hepatitis C IRES-mediated gene expression by small hairpin RNAs in human hepatocytes and mice. Ann N Y Acad Sci 1082:52\u201355","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"995_CR89","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","volume":"21","author":"AL Jackson","year":"2003","unstructured":"Jackson AL, Bartz SR et al (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21(6):635\u2013637","journal-title":"Nat Biotechnol"},{"issue":"7","key":"995_CR90","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1261\/rna.30706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson AL, Burchard J et al (2006a) Position-specific chemical modification of siRNAs reduces \u201coff-target\u201d transcript silencing. RNA 12(7):1197\u20131205","journal-title":"RNA"},{"issue":"7","key":"995_CR91","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1261\/rna.25706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson AL, Burchard J et al (2006b) Widespread siRNA \u201coff-target\u201d transcript silencing mediated by seed region sequence complementarity. RNA 12(7):1179\u20131187","journal-title":"RNA"},{"issue":"4","key":"995_CR92","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","volume":"23","author":"AD Judge","year":"2005","unstructured":"Judge AD, Sood V et al (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23(4):457\u2013462","journal-title":"Nat Biotechnol"},{"issue":"2","key":"995_CR93","first-page":"132","volume":"7","author":"RL Juliano","year":"2005","unstructured":"Juliano RL (2005) Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA. Curr Opin Mol Ther 7(2):132\u2013136","journal-title":"Curr Opin Mol Ther"},{"issue":"20","key":"995_CR94","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1182\/blood-2009-09-241000","volume":"115","author":"MM Juntilla","year":"2010","unstructured":"Juntilla MM, Patil VD et al (2010) AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. Blood 115(20):4030\u20134038","journal-title":"Blood"},{"issue":"1","key":"995_CR95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.biotechadv.2009.08.004","volume":"28","author":"S Khaliq","year":"2010","unstructured":"Khaliq S, Khaliq SA et al (2010) RNAi as a new therapeutic strategy against HCV. Biotechnol Adv 28(1):27\u201334","journal-title":"Biotechnol Adv"},{"issue":"2","key":"995_CR96","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","volume":"115","author":"A Khvorova","year":"2003","unstructured":"Khvorova A, Reynolds A et al (2003) Functional siRNAs and miRNAs exhibit strand bias. Cell 115(2):209\u2013216","journal-title":"Cell"},{"issue":"5","key":"995_CR97","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2144\/000112792","volume":"44","author":"D Kim","year":"2008","unstructured":"Kim D, Rossi J (2008) RNAi mechanisms and applications. Biotechniques 44(5):613\u2013616","journal-title":"Biotechniques"},{"key":"995_CR98","doi-asserted-by":"crossref","unstructured":"Kim DH, Rossi JJ (2009) Overview of gene silencing by RNA interference, Chap 16. Curr Protoc Nucleic Acid Chem (Unit 16 11)","DOI":"10.1002\/0471142700.nc1601s36"},{"issue":"2","key":"995_CR99","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt1051","volume":"23","author":"DH Kim","year":"2005","unstructured":"Kim DH, Behlke MA et al (2005) Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol 23(2):222\u2013226","journal-title":"Nat Biotechnol"},{"issue":"9","key":"995_CR100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nsmb1142","volume":"13","author":"DH Kim","year":"2006","unstructured":"Kim DH, Villeneuve LM et al (2006) Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 13(9):793\u2013797","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"995_CR101","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1593\/neo.07223","volume":"9","author":"N Kock","year":"2007","unstructured":"Kock N, Kasmieh R et al (2007) Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia 9(5):435\u2013442","journal-title":"Neoplasia"},{"issue":"2","key":"995_CR102","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10238-007-0125-z","volume":"7","author":"M Koldehoff","year":"2007","unstructured":"Koldehoff M, Steckel NK et al (2007) Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia. Clin Exp Med 7(2):47\u201355","journal-title":"Clin Exp Med"},{"issue":"1","key":"995_CR103","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/154545704322988067","volume":"14","author":"R Kole","year":"2004","unstructured":"Kole R, Vacek M et al (2004) Modification of alternative splicing by antisense therapeutics. Oligonucleotides 14(1):65\u201374","journal-title":"Oligonucleotides"},{"issue":"45","key":"995_CR104","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1038\/sj.onc.1209627","volume":"25","author":"T Komiya","year":"2006","unstructured":"Komiya T, Park Y et al (2006) Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene 25(45):6128\u20136132","journal-title":"Oncogene"},{"issue":"4","key":"995_CR105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cell.2008.06.034","volume":"134","author":"P Kumar","year":"2008","unstructured":"Kumar P, Ban HS et al (2008) T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134(4):577\u2013586","journal-title":"Cell"},{"issue":"5543","key":"995_CR106","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R et al (2001) Identification of novel genes coding for small expressed RNAs. Science 294(5543):853\u2013858","journal-title":"Science"},{"issue":"9","key":"995_CR107","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","volume":"12","author":"M Lagos-Quintana","year":"2002","unstructured":"Lagos-Quintana M, Rauhut R et al (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12(9):735\u2013739","journal-title":"Curr Biol"},{"issue":"15","key":"995_CR108","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","volume":"65","author":"CN Landen Jr","year":"2005","unstructured":"Landen C N Jr, Chavez-Reyes A et al (2005) Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 65(15):6910\u20136918","journal-title":"Cancer Res"},{"issue":"17","key":"995_CR109","doi-asserted-by":"crossref","first-page":"16949","DOI":"10.1074\/jbc.M501591200","volume":"280","author":"MA Langlois","year":"2005","unstructured":"Langlois MA, Boniface C et al (2005) Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells. J Biol Chem 280(17):16949\u201316954","journal-title":"J Biol Chem"},{"issue":"6","key":"995_CR110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/00313020500402276","volume":"37","author":"SR Larsen","year":"2005","unstructured":"Larsen SR, Rasko JE (2005) Lymphoproliferative disorders: prospects for gene therapy. Pathology 37(6):523\u2013533","journal-title":"Pathology"},{"issue":"3","key":"995_CR111","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2008.04.003","volume":"51","author":"SA Leachman","year":"2008","unstructured":"Leachman SA, Hickerson RP et al (2008) Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita. J Dermatol Sci 51(3):151\u2013157","journal-title":"J Dermatol Sci"},{"issue":"2","key":"995_CR112","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2009.273","volume":"18","author":"SA Leachman","year":"2010","unstructured":"Leachman SA, Hickerson RP et al (2010) First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 18(2):442\u2013446","journal-title":"Mol Ther"},{"issue":"5","key":"995_CR113","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL et al (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843\u2013854","journal-title":"Cell"},{"issue":"2","key":"995_CR114","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physiolgenomics.00095.2002","volume":"12","author":"HC Lee","year":"2003","unstructured":"Lee HC, Patel MK et al (2003) Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase. Physiol Genomics 12(2):147\u2013157","journal-title":"Physiol Genomics"},{"issue":"1","key":"995_CR115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB et al (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15\u201320","journal-title":"Cell"},{"key":"995_CR116","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1196\/annals.1348.006","volume":"1082","author":"M Li","year":"2006","unstructured":"Li M, Li H et al (2006) RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy. Ann N Y Acad Sci 1082:172\u2013179","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"995_CR117","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2007.03.008","volume":"129","author":"QJ Li","year":"2007","unstructured":"Li QJ, Chau J et al (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129(1):147\u2013161","journal-title":"Cell"},{"issue":"2","key":"995_CR118","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S et al (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10(2):137\u2013144","journal-title":"Hum Mol Genet"},{"issue":"14","key":"995_CR119","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1093\/nar\/gki762","volume":"33","author":"X Lin","year":"2005","unstructured":"Lin X, Ruan X et al (2005) siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res 33(14):4527\u20134535","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"995_CR120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1039\/b701169e","volume":"3","author":"P Lingor","year":"2007","unstructured":"Lingor P, Bahr M (2007) Targeting neurological disease with RNAi. Mol Biosyst 3(11):773\u2013780","journal-title":"Mol Biosyst"},{"key":"995_CR121","doi-asserted-by":"crossref","unstructured":"Lovett-Racke, AE (2009). Therapeutic potential of small interfering RNA for brain diseases. Therapeutic Ribonucleic Acids in Brain Tumors. Springer-Verlag, Berlin, pp 275\u2013295","DOI":"10.1007\/978-3-642-00475-9_13"},{"issue":"7043","key":"995_CR122","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834\u2013838","journal-title":"Nature"},{"issue":"1","key":"995_CR123","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2006.02.141","volume":"343","author":"Y Machida","year":"2006","unstructured":"Machida Y, Okada T et al (2006) rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse. Biochem Biophys Res Commun 343(1):190\u2013197","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"995_CR124","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1128\/MCB.12.11.5238","volume":"12","author":"L Manche","year":"1992","unstructured":"Manche L, Green SR et al (1992) Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol 12(11):5238\u20135248","journal-title":"Mol Cell Biol"},{"key":"995_CR125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.genom.8.080706.092424","volume":"8","author":"SE Martin","year":"2007","unstructured":"Martin SE, Caplen NJ (2007) Applications of RNA interference in mammalian systems. Annu Rev Genomics Hum Genet 8:81\u2013108","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"23","key":"995_CR126","doi-asserted-by":"crossref","first-page":"14849","DOI":"10.1073\/pnas.222406899","volume":"99","author":"LA Martinez","year":"2002","unstructured":"Martinez LA, Naguibneva I et al (2002) Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc Natl Acad Sci USA 99(23):14849\u201314854","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"995_CR127","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1073\/pnas.0308726100","volume":"101","author":"MM Maxwell","year":"2004","unstructured":"Maxwell MM, Pasinelli P et al (2004) RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc Natl Acad Sci USA 101(9):3178\u20133183","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"995_CR128","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","volume":"105","author":"JL McBride","year":"2008","unstructured":"McBride JL, Boudreau RL et al (2008) Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 105(15):5868\u20135873","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"995_CR129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/jhep.2003.50330","volume":"38","author":"AP McCaffrey","year":"2003","unstructured":"McCaffrey AP, Meuse L et al (2003a) A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice. Hepatology 38(2):503\u2013508","journal-title":"Hepatology"},{"issue":"6","key":"995_CR130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nbt824","volume":"21","author":"AP McCaffrey","year":"2003","unstructured":"McCaffrey AP, Nakai H et al (2003b) Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 21(6):639\u2013644","journal-title":"Nat Biotechnol"},{"issue":"3","key":"995_CR131","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1566523054064995","volume":"5","author":"TJ McCown","year":"2005","unstructured":"McCown TJ (2005) Adeno-associated virus (AAV) vectors in the CNS. Curr Gene Ther 5(3):333\u2013338","journal-title":"Curr Gene Ther"},{"issue":"10","key":"995_CR132","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrg908","volume":"3","author":"MT McManus","year":"2002","unstructured":"McManus MT, Sharp PA (2002) Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3(10):737\u2013747","journal-title":"Nat Rev Genet"},{"issue":"8","key":"995_CR133","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt1223","volume":"24","author":"JO McNamara 2nd","year":"2006","unstructured":"McNamara J O 2nd, Andrechek ER et al (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 24(8):1005\u20131015","journal-title":"Nat Biotechnol"},{"issue":"7006","key":"995_CR134","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature02873","volume":"431","author":"G Meister","year":"2004","unstructured":"Meister G, Tuschl T (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431(7006):343\u2013349","journal-title":"Nature"},{"issue":"12","key":"995_CR135","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","volume":"100","author":"VM Miller","year":"2003","unstructured":"Miller VM, Xia H et al (2003) Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 100(12):7195\u20137200","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"995_CR136","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/nar\/gkh208","volume":"32","author":"VM Miller","year":"2004","unstructured":"Miller VM, Gouvion CM et al (2004) Targeting Alzheimer\u2019s disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res 32(2):661\u2013668","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"995_CR137","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/oxfordjournals.hmg.a018923","volume":"9","author":"JP Mounsey","year":"2000","unstructured":"Mounsey JP, Mistry DJ et al (2000) Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Hum Mol Genet 9(15):2313\u20132320","journal-title":"Hum Mol Genet"},{"issue":"1\u20133","key":"995_CR138","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(03)01505-9","volume":"558","author":"A Muratovska","year":"2004","unstructured":"Muratovska A, Eccles MR (2004) Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett 558(1\u20133):63\u201368","journal-title":"FEBS Lett"},{"issue":"2","key":"995_CR139","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.nurt.2009.01.012","volume":"6","author":"F Noe","year":"2009","unstructured":"Noe F, Frasca A et al (2009) Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. Neurotherapeutics 6(2):300\u2013306","journal-title":"Neurotherapeutics"},{"issue":"3","key":"995_CR140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(01)00547-5","volume":"107","author":"A Nykanen","year":"2001","unstructured":"Nykanen A, Haley B et al (2001) ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107(3):309\u2013321","journal-title":"Cell"},{"issue":"5","key":"995_CR141","doi-asserted-by":"crossref","first-page":"e2248","DOI":"10.1371\/journal.pone.0002248","volume":"3","author":"Y Ohnishi","year":"2008","unstructured":"Ohnishi Y, Tamura Y et al (2008) Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. PLoS One 3(5):e2248","journal-title":"PLoS One"},{"issue":"20","key":"995_CR142","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1093\/nar\/gkn693","volume":"36","author":"T Ohrt","year":"2008","unstructured":"Ohrt T, Mutze J et al (2008) Fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy reveal the cytoplasmic origination of loaded nuclear RISC in vivo in human cells. Nucleic Acids Res 36(20):6439\u20136449","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"995_CR143","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.gt.3302694","volume":"13","author":"SI Pai","year":"2006","unstructured":"Pai SI, Lin YY et al (2006) Prospects of RNA interference therapy for cancer. Gene Ther 13(6):464\u2013477","journal-title":"Gene Ther"},{"issue":"2","key":"995_CR144","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1750-3639.2000.tb00263.x","volume":"10","author":"HL Paulson","year":"2000","unstructured":"Paulson HL (2000) Toward an understanding of polyglutamine neurodegeneration. Brain Pathol 10(2):293\u2013299","journal-title":"Brain Pathol"},{"issue":"24","key":"995_CR145","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1073\/pnas.210395797","volume":"97","author":"HL Paulson","year":"2000","unstructured":"Paulson HL, Bonini NM et al (2000) Polyglutamine disease and neuronal cell death. Proc Natl Acad Sci USA 97(24):12957\u201312958","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5550","key":"995_CR146","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1126\/science.1065806","volume":"294","author":"R Pawliuk","year":"2001","unstructured":"Pawliuk R, Westerman KA et al (2001) Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 294(5550):2368\u20132371","journal-title":"Science"},{"issue":"9","key":"995_CR147","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nmeth911","volume":"3","author":"Y Pei","year":"2006","unstructured":"Pei Y, Tuschl T (2006) On the art of identifying effective and specific siRNAs. Nat Methods 3(9):670\u2013676","journal-title":"Nat Methods"},{"issue":"8","key":"995_CR148","doi-asserted-by":"crossref","first-page":"a003640","DOI":"10.1101\/cshperspect.a003640","volume":"2","author":"N Perrimon","year":"2010","unstructured":"Perrimon N, Ni JQ et al (2010) In vivo RNAi: today and tomorrow. Cold Spring Harb Perspect Biol 2(8):a003640","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"995_CR149","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jgm.1500","volume":"12","author":"I Petrus","year":"2010","unstructured":"Petrus I, Chuah M et al (2010) Gene therapy strategies for hemophilia: benefits versus risks. J Gene Med 12(10):797\u2013809","journal-title":"J Gene Med"},{"issue":"12","key":"995_CR150","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1172\/JCI29236","volume":"116","author":"A Pfeifer","year":"2006","unstructured":"Pfeifer A, Eigenbrod S et al (2006) Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. J Clin Invest 116(12):3204\u20133210","journal-title":"J Clin Invest"},{"issue":"5321","key":"995_CR151","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"9","key":"995_CR152","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1517\/14728220903179338","volume":"13","author":"K Quon","year":"2009","unstructured":"Quon K, Kassner PD (2009) RNA interference screening for the discovery of oncology targets. Expert Opin Ther Targets 13(9):1027\u20131035","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"995_CR153","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1205","volume":"11","author":"GS Ralph","year":"2005","unstructured":"Ralph GS, Radcliffe PA et al (2005) Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 11(4):429\u2013433","journal-title":"Nat Med"},{"issue":"4","key":"995_CR154","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1207","volume":"11","author":"C Raoul","year":"2005","unstructured":"Raoul C, Abbas-Terki T et al (2005) Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 11(4):423\u2013428","journal-title":"Nat Med"},{"issue":"6","key":"995_CR155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.gt.3302690","volume":"13","author":"C Raoul","year":"2006","unstructured":"Raoul C, Barker SD et al (2006) Viral-based modelling and correction of neurodegenerative diseases by RNA interference. Gene Ther 13(6):487\u2013495","journal-title":"Gene Ther"},{"issue":"3","key":"995_CR156","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ng0796-325","volume":"13","author":"S Reddy","year":"1996","unstructured":"Reddy S, Smith DB et al (1996) Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 13(3):325\u2013335","journal-title":"Nat Genet"},{"issue":"6772","key":"995_CR157","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/35002607","volume":"403","author":"BJ Reinhart","year":"2000","unstructured":"Reinhart BJ, Slack FJ et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772):901\u2013906","journal-title":"Nature"},{"issue":"1","key":"995_CR158","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2008.01743.x","volume":"50","author":"V Riban","year":"2009","unstructured":"Riban V, Fitzsimons HL et al (2009) Gene therapy in epilepsy. Epilepsia 50(1):24\u201332","journal-title":"Epilepsia"},{"issue":"4","key":"995_CR159","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2007.04.016","volume":"26","author":"GB Robb","year":"2007","unstructured":"Robb GB, Rana TM (2007) RNA helicase A interacts with RISC in human cells and functions in RISC loading. Mol Cell 26(4):523\u2013537","journal-title":"Mol Cell"},{"issue":"2","key":"995_CR160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nsmb886","volume":"12","author":"GB Robb","year":"2005","unstructured":"Robb GB, Brown KM et al (2005) Specific and potent RNAi in the nucleus of human cells. Nat Struct Mol Biol 12(2):133\u2013137","journal-title":"Nat Struct Mol Biol"},{"issue":"10A","key":"995_CR161","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1101\/gr.2722704","volume":"14","author":"A Rodriguez","year":"2004","unstructured":"Rodriguez A, Griffiths-Jones S et al (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14(10A):1902\u20131910","journal-title":"Genome Res"},{"issue":"6","key":"995_CR162","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.gt.3302702","volume":"13","author":"E Rodriguez-Lebron","year":"2006","unstructured":"Rodriguez-Lebron E, Paulson HL (2006) Allele-specific RNA interference for neurological disease. Gene Ther 13(6):576\u2013581","journal-title":"Gene Ther"},{"issue":"4","key":"995_CR163","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","volume":"12","author":"E Rodriguez-Lebron","year":"2005","unstructured":"Rodriguez-Lebron E, Denovan-Wright EM et al (2005) Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington\u2019s disease transgenic mice. Mol Ther 12(4):618\u2013633","journal-title":"Mol Ther"},{"issue":"9","key":"995_CR164","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/mt.2009.123","volume":"17","author":"E Rodriguez-Lebron","year":"2009","unstructured":"Rodriguez-Lebron E, Gouvion CM et al (2009) Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer\u2019s disease. Mol Ther 17(9):1563\u20131573","journal-title":"Mol Ther"},{"issue":"19","key":"995_CR165","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.lfs.2006.06.011","volume":"79","author":"DW Sah","year":"2006","unstructured":"Sah DW (2006) Therapeutic potential of RNA interference for neurological disorders. Life Sci 79(19):1773\u20131780","journal-title":"Life Sci"},{"issue":"1","key":"995_CR166","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nbt1176","volume":"24","author":"S Samakoglu","year":"2006","unstructured":"Samakoglu S, Lisowski L et al (2006) A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat Biotechnol 24(1):89\u201394","journal-title":"Nat Biotechnol"},{"issue":"2","key":"995_CR167","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.expneurol.2005.12.024","volume":"198","author":"MK Sapru","year":"2006","unstructured":"Sapru MK, Yates JW et al (2006) Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi. Exp Neurol 198(2):382\u2013390","journal-title":"Exp Neurol"},{"issue":"45","key":"995_CR168","doi-asserted-by":"crossref","first-page":"44312","DOI":"10.1074\/jbc.M307089200","volume":"278","author":"S Saxena","year":"2003","unstructured":"Saxena S, Jonsson ZO et al (2003) Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem 278(45):44312\u201344319","journal-title":"J Biol Chem"},{"issue":"4","key":"995_CR169","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2002-06-1685","volume":"101","author":"M Scherr","year":"2003","unstructured":"Scherr M, Battmer K et al (2003) Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 101(4):1566\u20131569","journal-title":"Blood"},{"issue":"9","key":"995_CR170","doi-asserted-by":"crossref","first-page":"e7232","DOI":"10.1371\/journal.pone.0007232","volume":"4","author":"J Scholefield","year":"2009","unstructured":"Scholefield J, Greenberg LJ et al (2009) Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype. PLoS One 4(9):e7232","journal-title":"PLoS One"},{"issue":"2","key":"995_CR171","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","volume":"115","author":"DS Schwarz","year":"2003","unstructured":"Schwarz DS, Hutvagner G et al (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115(2):199\u2013208","journal-title":"Cell"},{"issue":"9","key":"995_CR172","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","volume":"2","author":"DS Schwarz","year":"2006","unstructured":"Schwarz DS, Ding H et al (2006) Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2(9):e140","journal-title":"PLoS Genet"},{"issue":"10","key":"995_CR173","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jgm.959","volume":"8","author":"A Sengupta","year":"2006","unstructured":"Sengupta A, Banerjee D et al (2006) Gene therapy for BCR-ABL\u00a0+\u00a0human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector. J Gene Med 8(10):1251\u20131261","journal-title":"J Gene Med"},{"key":"995_CR174","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/138920110792927766","volume":"11","author":"AA Seyhan","year":"2010","unstructured":"Seyhan AA, Ryan TE (2010) RNAi screening for the discovery of novel modulators of human disease. Curr Pharm Biotechnol 11:735\u2013756","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"995_CR175","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1261\/rna.7285805","volume":"11","author":"AA Seyhan","year":"2005","unstructured":"Seyhan AA, Vlassov AV et al (2005) Complete, gene-specific siRNA libraries: production and expression in mammalian cells. RNA 11(5):837\u2013846","journal-title":"RNA"},{"issue":"4","key":"995_CR176","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/oli.2007.0079","volume":"17","author":"AA Seyhan","year":"2007","unstructured":"Seyhan AA, Alizadeh BN et al (2007) RNA interference-mediated inhibition of Semliki Forest virus replication in mammalian cells. Oligonucleotides 17(4):473\u2013484","journal-title":"Oligonucleotides"},{"key":"995_CR301","doi-asserted-by":"crossref","unstructured":"Singer O, Marr RA et al (2005) Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 8(10):1343\u20131349","DOI":"10.1038\/nn1531"},{"issue":"5646","key":"995_CR177","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M et al (2003) Alpha-synuclein locus triplication causes Parkinson\u2019s disease. Science 302(5646):841","journal-title":"Science"},{"issue":"Pt 6","key":"995_CR178","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1042\/BST0320952","volume":"32","author":"CA Sledz","year":"2004","unstructured":"Sledz CA, Williams BR (2004) RNA interference and double-stranded-RNA-activated pathways. Biochem Soc Trans 32(Pt 6):952\u2013956","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"995_CR179","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1038","volume":"5","author":"CA Sledz","year":"2003","unstructured":"Sledz CA, Holko M et al (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5(9):834\u2013839","journal-title":"Nat Cell Biol"},{"issue":"6","key":"995_CR180","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nbt1101","volume":"23","author":"E Song","year":"2005","unstructured":"Song E, Zhu P et al (2005) Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 23(6):709\u2013717","journal-title":"Nat Biotechnol"},{"issue":"7014","key":"995_CR181","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","volume":"432","author":"J Soutschek","year":"2004","unstructured":"Soutschek J, Akinc A et al (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432(7014):173\u2013178","journal-title":"Nature"},{"issue":"6645","key":"995_CR182","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML et al (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"2","key":"995_CR183","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ijc.21286","volume":"118","author":"H Sumimoto","year":"2006","unstructured":"Sumimoto H, Hirata K et al (2006) Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi. Int J Cancer 118(2):472\u2013476","journal-title":"Int J Cancer"},{"issue":"10","key":"995_CR184","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/nn.2395","volume":"12","author":"HS Sun","year":"2009","unstructured":"Sun HS, Jackson MF et al (2009) Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci 12(10):1300\u20131307","journal-title":"Nat Neurosci"},{"issue":"8","key":"995_CR185","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1349-7006.2006.00234.x","volume":"97","author":"F Takeshita","year":"2006","unstructured":"Takeshita F, Ochiya T (2006) Therapeutic potential of RNA interference against cancer. Cancer Sci 97(8):689\u2013696","journal-title":"Cancer Sci"},{"issue":"1","key":"995_CR186","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1523\/JNEUROSCI.22-01-00133.2002","volume":"22","author":"K Tanemura","year":"2002","unstructured":"Tanemura K, Murayama M et al (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 22(1):133\u2013141","journal-title":"J Neurosci"},{"issue":"9","key":"995_CR187","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1158\/0008-5472.CAN-05-4292","volume":"66","author":"R Taulli","year":"2006","unstructured":"Taulli R, Scuoppo C et al (2006) Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Cancer Res 66(9):4742\u20134749","journal-title":"Cancer Res"},{"issue":"1","key":"995_CR188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20522","volume":"34","author":"R Tawil","year":"2006","unstructured":"Tawil R, Van Der Maarel SM (2006) Facioscapulohumeral muscular dystrophy. Muscle Nerve 34(1):1\u201315","journal-title":"Muscle Nerve"},{"issue":"7","key":"995_CR189","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nmd.2010.04.007","volume":"20","author":"R Tawil","year":"2010","unstructured":"Tawil R, van der Maarel S et al (2010) 171st ENMC international workshop: Standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 20(7):471\u2013475","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"995_CR190","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ng1611","volume":"37","author":"AH Ting","year":"2005","unstructured":"Ting AH, Schuebel KE et al (2005) Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat Genet 37(8):906\u2013910","journal-title":"Nat Genet"},{"issue":"1","key":"995_CR191","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1758-907X-1-14","volume":"1","author":"AK Vaishnaw","year":"2010","unstructured":"Vaishnaw AK, Gollob J et al (2010) A status report on RNAi therapeutics. Silence 1(1):14","journal-title":"Silence"},{"issue":"5507","key":"995_CR192","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","volume":"291","author":"JC Venter","year":"2001","unstructured":"Venter JC, Adams MD et al (2001) The sequence of the human genome. Science 291(5507):1304\u20131351","journal-title":"Science"},{"issue":"4","key":"995_CR193","first-page":"87340","volume":"2006","author":"L Venturini","year":"2006","unstructured":"Venturini L, Eder M et al (2006) RNA-mediated gene silencing in hematopoietic cells. J Biomed Biotechnol 2006(4):87340","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"995_CR194","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/oli.2006.0069","volume":"17","author":"AV Vlassov","year":"2007","unstructured":"Vlassov AV, Korba B et al (2007) shRNAs targeting hepatitis C: effects of sequence and structural features, and comparison with siRNA. Oligonucleotides 17(2):223\u2013236","journal-title":"Oligonucleotides"},{"key":"995_CR195","doi-asserted-by":"crossref","unstructured":"Wallace, LM, Garwick SE et al (2010) RNAi therapy for dominant muscular dystrophies and other myopathies. Muscle Gene Therapy 99\u2013115. doi: 10.1007\/978-1-4419-1207-7_7","DOI":"10.1007\/978-1-4419-1207-7_7"},{"issue":"3","key":"995_CR196","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","volume":"53","author":"YL Wang","year":"2005","unstructured":"Wang YL, Liu W et al (2005) Clinico-pathological rescue of a model mouse of Huntington\u2019s disease by siRNA. Neurosci Res 53(3):241\u2013249","journal-title":"Neurosci Res"},{"issue":"3","key":"995_CR197","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cell.2008.12.023","volume":"136","author":"L Weinmann","year":"2009","unstructured":"Weinmann L, Hock J et al (2009) Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell 136(3):496\u2013507","journal-title":"Cell"},{"issue":"29","key":"995_CR198","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1073\/pnas.0802759105","volume":"105","author":"MD White","year":"2008","unstructured":"White MD, Farmer M et al (2008) Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci USA 105(29):10238\u201310243","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"995_CR199","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","volume":"75","author":"B Wightman","year":"1993","unstructured":"Wightman B, Ha I et al (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75(5):855\u2013862","journal-title":"Cell"},{"issue":"37","key":"995_CR200","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1038\/sj.onc.1205653","volume":"21","author":"M Wilda","year":"2002","unstructured":"Wilda M, Fuchs U et al (2002) Killing of leukemic cells with a BCR\/ABL fusion gene by RNA interference (RNAi). Oncogene 21(37):5716\u20135724","journal-title":"Oncogene"},{"issue":"6","key":"995_CR201","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2002-12-3899","volume":"102","author":"L Wohlbold","year":"2003","unstructured":"Wohlbold L, van der Kuip H et al (2003) Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 102(6):2236\u20132239","journal-title":"Blood"},{"key":"995_CR202","first-page":"3","volume":"54","author":"JA Wolff","year":"2005","unstructured":"Wolff JA, Budker V (2005) The mechanism of naked DNA uptake and expression. Adv Genet 54:3\u201320","journal-title":"Adv Genet"},{"issue":"8","key":"995_CR203","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm1076","volume":"10","author":"H Xia","year":"2004","unstructured":"Xia H, Mao Q et al (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10(8):816\u2013820","journal-title":"Nat Med"},{"issue":"1","key":"995_CR204","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto A, Lucas JJ et al (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 101(1):57\u201366","journal-title":"Cell"},{"issue":"1","key":"995_CR205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2007.08.004","volume":"117","author":"M Yang","year":"2008","unstructured":"Yang M, Mattes J (2008) Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol Ther 117(1):94\u2013104","journal-title":"Pharmacol Ther"},{"issue":"24","key":"995_CR206","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1101\/gad.1158803","volume":"17","author":"R Yi","year":"2003","unstructured":"Yi R, Qin Y et al (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17(24):3011\u20133016","journal-title":"Genes Dev"},{"issue":"5740","key":"995_CR207","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1111444","volume":"309","author":"PD Zamore","year":"2005","unstructured":"Zamore PD, Haley B (2005) Ribo-gnome: the big world of small RNAs. Science 309(5740):1519\u20131524","journal-title":"Science"},{"issue":"1","key":"995_CR208","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(00)80620-0","volume":"101","author":"PD Zamore","year":"2000","unstructured":"Zamore PD, Tuschl T et al (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101(1):25\u201333","journal-title":"Cell"},{"issue":"11","key":"995_CR209","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1158\/1078-0432.CCR-03-0740","volume":"10","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Zhang YF et al (2004) Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 10(11):3667\u20133677","journal-title":"Clin Cancer Res"},{"issue":"2","key":"995_CR210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jcp.20869","volume":"210","author":"B Zhang","year":"2007","unstructured":"Zhang B, Wang Q et al (2007) MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210(2):279\u2013289","journal-title":"J Cell Physiol"},{"issue":"12","key":"995_CR211","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmeth812","volume":"2","author":"HF Zhao","year":"2005","unstructured":"Zhao HF, L\u2019Abbe D et al (2005) High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion. Nat Methods 2(12):967\u2013973","journal-title":"Nat Methods"},{"issue":"8","key":"995_CR212","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/mt.2008.92","volume":"16","author":"J Zhou","year":"2008","unstructured":"Zhou J, Li H et al (2008) Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol Ther 16(8):1481\u20131489","journal-title":"Mol Ther"},{"issue":"4","key":"995_CR213","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4161\/cbt.4.4.1616","volume":"4","author":"H Zhu","year":"2005","unstructured":"Zhu H, Guo W et al (2005) Enhancing TRAIL-induced apoptosis by Bcl-X(L) siRNA. Cancer Biol Ther 4(4):393\u2013397","journal-title":"Cancer Biol Ther"},{"issue":"7089","key":"995_CR214","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","volume":"441","author":"TS Zimmermann","year":"2006","unstructured":"Zimmermann TS, Lee AC et al (2006) RNAi-mediated gene silencing in non-human primates. Nature 441(7089):111\u2013114","journal-title":"Nature"},{"key":"995_CR215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi HY, Orr HT (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23:217\u2013247","journal-title":"Annu Rev Neurosci"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-011-0995-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00439-011-0995-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-011-0995-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T12:21:40Z","timestamp":1637583700000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00439-011-0995-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,3]]},"references-count":217,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1007\/s00439-011-0995-8","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,3]]}}}